A government watchdog agency rejected a high-profile whistleblower’s claims that the FDA improperly approved medical imaging devices for breast-cancer and colon-cancer screening.
WSJ.com US News, Wall Street Journal
Wed, 10/07/2015 - 6:24pm
A government watchdog agency rejected a high-profile whistleblower’s claims that the FDA improperly approved medical imaging devices for breast-cancer and colon-cancer screening.